Absci Corp (ABSI)
4.21
-0.04
(-0.94%)
USD |
NASDAQ |
May 31, 16:00
4.19
-0.02
(-0.48%)
Pre-Market: 20:00
Absci Accounts Payable (Quarterly): 1.653M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 1.653M |
| December 31, 2023 | 1.503M |
| September 30, 2023 | 1.909M |
| June 30, 2023 | 1.851M |
| March 31, 2023 | 1.933M |
| December 31, 2022 | 2.412M |
| September 30, 2022 | 1.858M |
| Date | Value |
|---|---|
| June 30, 2022 | 5.47M |
| March 31, 2022 | 6.739M |
| December 31, 2021 | 8.385M |
| September 30, 2021 | 6.372M |
| June 30, 2021 | 9.004M |
| March 31, 2021 | 8.449M |
| December 31, 2020 | 2.116M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
1.503M
Minimum
Dec 2023
9.004M
Maximum
Jun 2021
4.261M
Average
2.264M
Median
Accounts Payable (Quarterly) Benchmarks
| Eli Lilly and Co | 2.474B |
| Creative Medical Technology Holdings Inc | 0.3368M |
| CytomX Therapeutics Inc | 1.964M |
| Bristol-Myers Squibb Co | 3.539B |
| Recursion Pharmaceuticals Inc | 5.115M |